Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)

NCT03050229 is registered in ClinicalTrials.gov with Jichi Medical University as lead sponsor.

NCT NCT03050229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03050229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
Lead sponsor
Jichi Medical University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
March 31, 2018
Enrollment
174 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

nocturnal hypertension, t2dm (type 2 diabetes mellitus)